Molecular determinants of susceptibility to oncolytic vesicular stomatitis virus in pancreatic adenocarcinoma. - Wikidata - awgldk - TriplyDB

Molecular determinants of susceptibility to oncolytic vesicular stomatitis virus in pancreatic adenocarcinoma.

Molecular determinants of susceptibility to oncolytic vesicular stomatitis virus in pancreatic adenocarcinoma.

http://www.wikidata.org/entity/Q37646792

about

Big Data Offers Novel Insights for Oncolytic Virus Immunotherapy Mechanistic insights into the oncolytic activity of vesicular stomatitis virus in cancer immunotherapy Phase 1 study of intratumoral Pexa-Vec (JX-594), an oncolytic and immunotherapeutic vaccinia virus, in pediatric cancer patients.Murine Tumor Models for Oncolytic Rhabdo-Virotherapy.Gene expression profiling of hematologic malignant cell lines resistant to oncolytic virus treatment Recent advances in vesicular stomatitis virus-based oncolytic virotherapy: a 5-year update.Preclinical Development of Oncolytic Immunovirotherapy for Treatment of HPVPOS Cancers.

P2860

Q26767209-9CAD4DBE-38D7-4D5E-BBE5-B5EB9FF9A770 Q28083766-17991341-34E1-4A85-BD58-8C70B32EFE53 Q35153121-E77B1D82-9D6A-4C4F-84E2-769BCC9C6746 Q36751597-099487CB-7DB9-4361-8E8D-C36CC62D5FC5 Q37702075-6BE82452-606B-4EB6-A175-F5AD4D1834D3 Q45324769-241B4D7A-0589-40E8-ACEE-106A98953479 Q55652233-FD5DB19E-B47E-4F91-AAD8-0A2D234B56F1

P2860

Molecular determinants of susceptibility to oncolytic vesicular stomatitis virus in pancreatic adenocarcinoma.

http://www.wikidata.org/entity/Q37646792

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 21 October 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Molecular determinants of susc ...... in pancreatic adenocarcinoma.

@en

Molecular determinants of susc ...... in pancreatic adenocarcinoma.

@nl

type

label

Molecular determinants of susc ...... in pancreatic adenocarcinoma.

@en

Molecular determinants of susc ...... in pancreatic adenocarcinoma.

@nl

prefLabel

Molecular determinants of susc ...... in pancreatic adenocarcinoma.

@en

Molecular determinants of susc ...... in pancreatic adenocarcinoma.

@nl

P1433

Q37646792-2BC2D886-8437-46CC-A2AB-BE826FBA08A4

P1476

Q37646792-9010FDDD-2DC6-43C5-888E-329E6AFE0C9B

P2093

Q37646792-09248F68-1040-4489-9900-6341655C4A2A

Q37646792-0B317C35-6FAB-4686-A6DE-51DBCABF0755

Q37646792-162ED70D-48C0-4623-91D3-D8D85C483042

Q37646792-4A28C8F3-E037-4AD2-9D07-84CE2D4D8B2A

Q37646792-7EC8BA89-2F9B-4E29-924D-961E74D4CA2A

Q37646792-C41E2EBE-A425-4A78-A4D2-C71705FE562E

Q37646792-CD33EF57-C7C7-498C-8D7C-868D411DD34D

P2860

Q37646792-04AD738B-2CDE-4D45-A058-016CB351B17A

Q37646792-078A4EF4-8DF3-4613-938F-7177A17AA531

Q37646792-1D534FD7-6105-4E68-87AF-CE001B7CDE2B

Q37646792-265AAC77-1C00-42D0-ACAE-3B6092369BEE

Q37646792-27F931C3-B77F-4865-A398-5E82C9327CED

Q37646792-29AF6BAE-8DD8-4D7F-B11A-4027F19C65E2

Q37646792-29BCF993-7A31-41A6-9017-BA5E7A025A92

Q37646792-2A082190-BAF7-4317-B24A-1DDC4764B90A

Q37646792-2A411B90-8914-49DB-AF04-431FBD8FB8EB

Q37646792-3C94AE69-1B86-43CF-864E-92D15CAB48FF

P304

Q37646792-5EE37C1F-6DFA-4520-89CA-214E3012932F

P31

Q37646792-01EE8FF5-6FD8-4653-9C19-ED336ADFB427

P356

Q37646792-7389ADAE-FA5E-4E77-AE34-9A9DAB4CA380

P433

Q37646792-5F717D76-0223-4FC8-B4A1-BD06905BAB2E

P478

Q37646792-B3DBCC8C-A15B-4462-A69E-9CC2D59CAA05

P577

Q37646792-FBEB98F4-48B3-49CB-90A1-5C577354485F

P698

Q37646792-F1EF25D7-7840-4163-9BAC-72365925F477

P921

Q37646792-5E82C198-8E33-4728-9EFD-DBFFEA945CA5

Q37646792-64EB5AC3-1015-4253-BB03-C6159EDF2881

P932

Q37646792-7C6A8117-6CE2-43E8-8238-66391606AFBB

P356

J.JSS.2013.10.032

P1433

Journal of Surgical Research

P1476

Molecular determinants of susc ...... in pancreatic adenocarcinoma.

@en

P2093

Aaron U Blackham

http://www.w3.org/2001/XMLSchema#string

Douglas S Lyles

http://www.w3.org/2001/XMLSchema#string

Greg B Russell

http://www.w3.org/2001/XMLSchema#string

John H Stewart

http://www.w3.org/2001/XMLSchema#string

Joseph Sirintrapun

http://www.w3.org/2001/XMLSchema#string

Mark Willingham

http://www.w3.org/2001/XMLSchema#string

Scott A Northrup

http://www.w3.org/2001/XMLSchema#string

P2860

Cancer statistics, 2010

A comparison of normalization methods for high density oligonucleotide array data based on variance and bias

Linear models and empirical bayes methods for assessing differential expression in microarray experiments

LDL receptor and its family members serve as the cellular receptors for vesicular stomatitis virus

Targeting of interferon-beta to produce a specific, multi-mechanistic oncolytic vaccinia virus

The low-density lipoprotein receptor gene family: multiple roles in lipid metabolism.

Evaluation of an attenuated vesicular stomatitis virus vector expressing interferon-beta for use in malignant pleural mesothelioma: heterogeneity in interferon responsiveness defines potential efficacy.

Matrix protein and another viral component contribute to induction of apoptosis in cells infected with vesicular stomatitis virus.

Exploiting tumor-specific defects in the interferon pathway with a previously unknown oncolytic virus.

VSV strains with defects in their ability to shutdown innate immunity are potent systemic anti-cancer agents.

P304

412-426

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.JSS.2013.10.032

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

187

http://www.w3.org/2001/XMLSchema#string

P577

2013-10-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24252853

http://www.w3.org/2001/XMLSchema#string

P921

oncolytic virus

P932

3959227

http://www.w3.org/2001/XMLSchema#string